Attending this event?
Welcome to the interactive web schedule for the 2019 Midwest Fish & Wildlife Conference! The schedule is subject to change (as of November 7, 2018). Please check back for updates. To return to the main Conference website, go to: www.midwestfw.org.

The conference schedule is hosted in SCHED which allows you to search within the schedule, and filter the schedule to show items only occurring on a certain date or within a track/symposia.
  • To view only a certain type of presentation or track, locate the heading "Filter By Type" in the navigation bar. As an example, try clicking on "T01: Fisheries: Great Lakes I".
  • The default view for the schedule is "Simple" which only shows the start time and title of the agenda item. Hover over the button that says "Schedule" to see the different view options. The "Expanded" option will show start and end times, room location, and session description, if there is one.
  • You can build your own schedule by creating a free account with SCHED by selecting "SIGN UP." Watch the "how-to" video to learn more about using Sched. 
  • PLEASE NOTE: Adding agenda items to your schedule through this app does not sign you up for a session. If an agenda item says "pre-registration required" or charges an additional fee, you need to add the item to your registration through the online registration system

View analytic
Tuesday, January 29 • 2:40pm - 3:00pm
(SYMPOSIA-11) Update on Zequanox® Molluscicide as Management Tool for Invasive Dreissenid Mussels

Sign up or log in to save this to your schedule and see who's attending!

AUTHORS: Seth Donrovich, Marrone Bio Innovations

ABSTRACT: Zequanox molluscicide, a biological control for invasive dreissenid mussels, has been available for commercial use in enclosed and open water systems for approximately six years. During this time, the product has undergone development and been strategized for a variety of applications and markets. The product was recently trialed in Florida on Mytilopsis leucophaeata, with enough activity to warrant further experimentation. A biobox demonstration trial has been conducted at a hydroelectric generating station in Spain, the first trial of Zequanox in the EU. Furthermore, recently developments in fermentation has led to reduced product costs, and treatment strategies continue to be optimized with dose and hold and low dose maintenance programs being implemented. MBI looks forward to continuing collaboration on product development for use in enclosed water systems, as well as looking to optimize the product for open water applications, including development of a slow release granule or encapsulated formulation.   

Tuesday January 29, 2019 2:40pm - 3:00pm